Global HIV Drugs Market is Expected to Reach $36.49 Billion by 2027 | Pfizer Inc., Johnson & Johnson, Cipla Limited, Gilead Sciences, Inc.

 According to a new report published by Allied Market Research, titled, “Global HIV Drugs Market by Medication Class and Region: Global Opportunity Analysis and Industry Forecast, 2020–2027," The global HIV drugs market accounted for $30.89 billion in 2019, and is expected to reach $36.49 billion by 2027, registering a CAGR of 3.8% from 2020 to 2027. Human immunodeficiency virus (HIV) is one of the most challenging infectious diseases that affected around 39.6 million people globally by the end of 2018, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). Antiretroviral Therapy (ART) drugs are used for the treatment of HIV as they prevent the growth of the HIV virus.

♦ Download Free Sample Report Here:
https://www.alliedmarketresearch.com/request-sample/1867

Surge in the number of HIV-infected patients across the globe and various initiatives taken by different government associations to raise awareness drive the growth of the global HIV drugs market. On the other hand, strict regulatory requirements for the approval and commercialization of HIV drugs impede the growth to some extent. However, rise in number of products in the pipeline is anticipated to pave the way for lucrative opportunities in the near future.

Human immunodeficiency virus (HIV) is one of the most challenging infectious diseases that affected around 39.6 million people globally by the end of 2018, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). Antiretroviral Therapy (ART) drugs are used for the treatment of HIV as they prevent the growth of the HIV virus.

Covid-19 scenario:

Disrupted of land & air transport services and failure of suppliers to deliver ARVs on time impacted the global market for HIV drugs negatively.

At the same time, rescheduling of HIV treatment measures has led to huge backlog of patients to deal with in the near future.

Nevertheless, as the lockdown has loosened off, private clinics that treat HIV are reopening yet again, and the market is projected to recover soon.

♦ For Purchase Enquiry at:
https://www.alliedmarketresearch.com/purchase-enquiry/1867

Major Key Players Covered -
Key players in this market have adopted new product launch as the preferred strategy to expand their business.
The key players profiled in this report include:
Boehringer Ingelheim International GmbH,
Merck & Co., Inc.,
GalaxoSmithKline plc. AbbVie,
F. Hoffmann-La Roche Ltd.,
Teva Pharmaceutical Industries Ltd.,
Pfizer Inc.,
Gilead Sciences, Inc.,
Johnson & Johnson, and
Cipla Limited.

Key findings of the study 

  • North America accounted for 48.40% market share in 2019, and is expected to maintain this trend over the forecast period.
  • On the basis of medication class, the multi-class combination drugs segment is anticipated to grow at a CAGR of 4.1% from 2020 to 2027.
  • The Asia-Pacific HIV drugs market is estimated to grow at a CAGR of 4.4% during the forecast period.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

Comments

Post a Comment

Popular posts from this blog

Cell Culture Market Grows as Biotechnology Companies Invest Heavily in Drug Development | CAGR of 10.9%

Image
Allied Market Research recently said “ Cell Culture Market  by Product, Application, and End User: Opportunity Analysis and Industry Forecast, 2020–2027 ," the global cell culture market accounted for $16,107.7 million in 2019, and is expected to reach $36,926.80 million by 2027, registering a CAGR of 10.9% from 2020 to 2027. Increased awareness of the use of cell culture and research and financial growth related to research and growth in cancer-related research are major global cell culture market trends. ♦ ๐‘๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ - https://www.alliedmarketresearch.com/request-sample/3569 ๐—–๐—ข๐—ฉ๐—œ๐——-๐Ÿญ๐Ÿต ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜ ๐—”๐—ป๐—ฎ๐—น๐˜†๐˜€๐—ถ๐˜€ (๐—ฃ๐—ฟ๐—ฒ & ๐—ฃ๐—ผ๐˜€๐˜) - The Covid-19 outbreak has increased the demand for cell culture products to understand the disease and develop therapeutic interventions. Moreover, cell culture offers an opportunity to understand lung disease mechanisms at a cellular level and target pathogenic processes. This h...
Read more

Sleep Aids Market to Reach $111.92 Billion by 2030 | Enhancing Well-Being with Better Sleep

Image
Sleep aids are substances or methods used to help people fall asleep and stay asleep. They are commonly used to treat sleep disorders such as insomnia or to help with temporary sleep problems due to stress, jet lag, or other factors. the  sleep aids market  generated $59.8 billion in 2020, and is projected to reach $111.9 billion by 2030, witnessing a CAGR of 6.9% from 2021 to 2030. Examples of sleep aids include: Medications: Prescription sleep medications such as benzodiazepines, non-benzodiazepine hypnotics, and antihistamines. Over-the-counter remedies: Melatonin, valerian root, and other herbal supplements. Behavioral changes: Establishing a regular sleep schedule, avoiding screens before bedtime, and creating a relaxing bedtime routine. Devices: White noise machines, sleep masks, and weighted blankets can help create a more conducive sleep environment. It's important to use sleep aids with caution and under the guidance of a healthcare professional...
Read more

Pacemaker Market: Pacemaker to Play Major Role in $6,678.2 Million Economic Boost

A pacemaker is a small medical device that helps regulate an individual's heart rate. It is typically implanted under the skin of the chest or abdomen, and it sends electrical impulses to the heart to help it beat in a regular rhythm. Pacemakers are commonly used to treat various heart conditions that can cause an irregular or slow heartbeat, such as atrial fibrillation, heart block, or bradycardia. The device works by sensing the heart's electrical activity and sending electrical impulses to the heart muscle when necessary to keep it beating at a normal pace. The global pacemaker market size was valued at $4,667.2 million in 2020, and is projected to reach $6,678.2 million by 2030, registering a CAGR of 3.7% from 2021 to 2030. ♦ ๐ƒ๐จ๐ฐ๐ง๐ฅ๐จ๐š๐ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐๐ƒ๐… ๐Ž๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ : https://www.alliedmarketresearch.com/request-sample/1455 Pacemakers come in various types, depending on the specific needs of the patient. Some pacemakers are designed to res...
Read more